InMed Pharmaceuticals
Request Update
Total Investment:
CATEGORY Cannabinoids
FOUNDED 2014
HQ Canada
THE BASICS

InMed Pharmaceuticals is developing a proprietary cannabinoid bio-synthetic manufacturing platform using E.coli bacteria as the host organism. The company is focused on the clinical development of proprietary cannabinoid formulations for the treatment of epidermolysis bullosa, glaucoma, and orofacial pain.

GO DEEPER
CBT INSIGHTS
INVESTMENTS
×
It's free to read exclusive
CBT content To keep viewing profiles and access exclusive data, register for a free Cell Based Tech account.

>To login, please enter your email address

Just A Few More Details
keyboard_arrow_down
  • Find investment opportunity
  • Find investors
  • Market analysis/research
  • Other
keyboard_arrow_down
  • Investment/Finance
  • Business Development
  • Engineering/Scientist
  • IT
  • Marketing/Advertising
  • Sales
  • Other